Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors 
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring 
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project 
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence 
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake 
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth 
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs 
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance 
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters 
Samsung C&T Corp. posted a 269.9 billion won net profit for the fourth quarter, plunging 23.5 percent from a year earlier, due to reduced gains from equity ties with Samsung Biologics Co and increased costs in its trading business.
Fourth-quarter operating profit stood at 256.4 billion won, down 21 percent from the year before, while revenue rose 6.3 percent to 8.18 trillion won.
Samsung C&T holds a 43.4 percent stake in Samsung Biologics, whose fourth-quarter net profit plummeted 54.3 percent from the previous year to 96.2 billion won.
For the whole of 2020, Samsung C&T's net profit was up 10.8 percent on-year to 1.16 trillion won.
Operating income was 857.1 billion won, down 1.1 percent from a year earlier, while sales fell 1.8 percent to 30.2 trillion won.
Samsung C&T's trading business unit also increased sales by 5.1 percent on-year to 3.6 trillion won, but operating profit dropped 40 percent to 12 billion won due to rising shipping costs.
